William E. Solander

Representative Matters

• Represented Sanofi Genzyme against several generics on patents relating to Cerdelga® for the treatment of Gaucher disease (D. Del.)
• Represented Grünenthal against Antecip in contested proceedings in the USPTO relating to the use of bisphosphonates for the treatment of chronic pain (PTAB)
• Represented Sanofi against several generics on patents relating to Jevtana® for the treatment of prostate cancer (D.N.J., PTAB, Fed. Cir.)
• Represented Sanofi against several generics on patents relating to Multaq® for the treatment of atrial fibrillation (D. Del., Fed. Cir.)
• Represented Hoechst GmbH against Genentech, Inc., in an arbitration before the ICC International Court of Arbitration concerning royalties due under a terminated license involving eukaryotic protein expression technologies, and Sanofi-Aventis Deutschland GmbH against Genentech and Biogen-IDEC on patents covering those technologies
• Represented LEO Pharma against Tolmar Inc. and Perrigo Inc. on patents related to Taclonex, a topical anti-psoriatic medication
• Represented Sepracor Pharmaceuticals against Sandoz Inc., et al. on patents related to Clarinex®, an allergy medication
• Represented Sanofi against Sandoz Inc., et al. on a patent related to Ambien CR®, a sleep aid
• Represented Sanofi in Sanofi v. Sandoz Inc., et al. on a patent related to Eloxatin®, a platinum-containing anti-cancer drug
• Represented Novartis Pharmaceuticals Corporation against Mylan Pharmaceuticals on a patent related to Femara®, an aromatase inhibitor
• Represented Bristol-Myers Squibb against Repligen in an inventorship lawsuit related to Bristol-Myers Squibb’s protein-fusion drug Orencia®
• Represented Sanofi and Bristol-Myers Squibb against Apotex, et al. on patents covering Plavix®, a leading anti-thrombotic agent
• Represented Sanofi and Bristol-Myers Squibb against Sun Pharmaceuticals on a patent related to the crystalline form of the active ingredient in Plavix®
• Represented Novartis Pharmaceuticals Corporation against Dr. Reddy’s Laboratories Ltd. on patents covering Lamisil®, an anti-fungal medicine
• Represented Bristol-Myers Squibb against Rhône-Poulenc Rorer, Inc. et al. on patents related to semi-synthetic process technology for making Taxol®
• Represented Yamanouchi against Danbury Pharmacal on a patent related to Pepcid®, an anti-ulcer drug

Representative Clients

• Astellas Pharma
• Bristol-Myers Squibb 
• Gilead
• Hoechst GmbH
• LEO Pharma
• Novartis
• Sanofi
• Sunovion Pharmaceuticals
• Warner Chilcott

Education

• J.D. Chicago Kent College of Law 1995
• B.S. Chemistry California Polytechnic State University 1991

Bar Admissions

• New York

Court Admissions

• U.S. Court of Appeals for the Federal Circuit
• U.S. District Court for the Southern District of New York

Professional Memberships and Activities

• Speaks and writes frequently on litigation strategy, polymorph patents, and Hatch-Waxman litigation

Mentored by the renowned patent litigator Robert Baechtold until his retirement, Bill has earned his own “fantastic reputation” as “a truly excellent patent litigator” (Chambers USA).

• Named in Best Lawyers in America, 2012 - 2020
• Recognized in Chambers USA, 2008 - 2018
• Recognized in Managing Intellectual Property, IP Star, 2013 - 2019
• Included in IAM Patent 1000, 2012 - 2018
• Listed in Super Lawyers: New York Metro Edition, 2013 - 2019
• Recognized by LMG Life Sciences, 2016 - 2018
• Recognized in Legal 500 for Patent Litigation – Full Coverage, 2014, 2016 - 2018
• Recognized in IAM Life Sciences 250, 2010, 2011
• Listed in Legal Media Group Guide to the World’s Leading Patent Law Practitioners, 2007